Signal transduction by the cytoplasmic domain of NEUREGULIN-1 and its roles during neuronal aging

Current Signal Transduction Therapy

Volumn 2, Issue 3, 2007, Pages 240-245

  Bao, Jianxin ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Aging; Alzheimer; Intracellular domain; Neuregulin 1; PSD 95; Synapse

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; NEU DIFFERENTIATION FACTOR; NEUROTRANSMITTER; POSTSYNAPTIC DENSITY PROTEIN 95; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ALZHEIMER DISEASE; CELL AGING; CELL NUCLEUS; CYTOPLASM; DEGENERATIVE DISEASE; EXCITOTOXICITY; GENE EXPRESSION; HUMAN; LEARNING; MEMORY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE; UPREGULATION;

EID: 34848914016     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436207781745328     Document Type: Review

References (102)

1. Oehlen B, Cross FR. Signal transduction in the budding yeast Saccharomyces cerevisiae. Curr Opin Cell-Biol 1994; 6: 836-41.
2. Wang Y, Dohlman HG. Pheromone signaling mechanisms in yeast: a prototypical sex machine. Science 2004; 306: 1508-09.
3. Massague J, Pandiella A. Membrane-anchored growth factors: Annu Rev Biochem 1993; 62: 515-41.
4. Ward CW, Garrett TP. Structural relationships between the insulin receptor and epidermal growth factor receptor families and other proteins. Curr Opin Drug Discov Dev 2004; 7: 630-38.
5. Peles E, Yarden Y. Neu and its ligands: from an oncogene to neural factors. Bioessays 1993; 15: 815-24.
6. Burden S, Yarden Y. Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis. Neuron 1997; 18: 847-55.
7. Fischbach GD, Rosen KM. ARIA: a neuromuscular junction neuregulin. Annu Rev Neurosci 1997; 20: 429-58.
8. Gassmann M, Lemke G. Neuregulins and neuregulin receptors in neural development. Curr Opin Neurobiol 1997; 7: 87-92.
9. Crone SA, Lee KF. Gene targeting reveals multiple essential functions of the neuregulin signaling system during development of the neuroendocrine and nervous systems. Ann N Y Acad Sci 2002; 971: 547-53.
10. Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003; 284: 14-30.
11. Garratt AN, Ozcelik C, Birchmeier C. ErbB2 pathways in heart and neural diseases. Trends Cardiovasc Med 2003; 13: 80-6.
12. Cannella B, Hoban CJ, Gao YL, et al. The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci USA 1998; 95: 10100-5.
13. Chaudhury AR, Gerecke KM, Wyss JM, Morgan DG, Gordon MN, Carroll SL. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 2003; 62: 42-54.
14. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K. Neuregulin 1 and schizophrenia. Ann Med 2004; 36: 62-71.
15. Go RC, Perry RT, Wiener H, et al. Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. Am J Med Genet B Neuropsychiatr Genet 2005; 139B(1): 28-32.
16. Busfield SJ, Michnick DA, Chickering TW, et al. Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol Cell Biol 1997; 17: 4007-14.
17. Carraway KL 3rd, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M, Lai C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 1997; 387: 512-16.
18. Chang H, Riese DJ 2nd, Gilbert W, Stern DF, McMahan UJ. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 1997; 387: 509-12.
19. Zhang D, Sliwkowski MX, Mark M, et al. Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A 1997; 94: 9562-7.
20. Harari D, Tzahar E, Romano J, et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 1999; 18: 2681-9.
21. Talmage DA, Role LW. Multiple personalities of neuregulin gene family members. J Comp Neurol 2004; 472: 134-9.
22. Steinthorsdottir V, Stefansson H, Ghosh S, et al. Multiple novel transcription initiation sites for NRG1. Gene 2004; 342: 97-105.
23. Liu X, Hwang H, Cao L, et al. Release of the neuregulin functional polypeptide requires its cytoplasmic tail. J Biol Chem 1998; 273: 34335-40.
24. Wang JY, Frenzel KE, Wen D, Falls DL. Transmembrane neuregulins interact with LIM kinase 1, a cytoplasmic protein kinase implicated in development of visuospatial cognition. J Biol Chem 1998; 273: 20525-34.
25. Bao J, Wolpowitz D, Role LW, Talmage DA. Back signaling by the Nrg-1 intracellular domain. J Cell Biol 2003; 161: 1133-41.
26. Bao J, Lin H, Ouyang Y, et al. Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci 2004; 7: 1250-8.
27. Wen D, Suggs SV, Karunagaran D, et al. Structural and functional aspects of the multiplicity of Neu differrentiation factors. Mol Cell Biol 1994; 14: 1909-19.
28. Pinkas-Kramarski R, Shelly M, Guarino BC, et al. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. Mol Cell Biol 1998; 18: 6090-101.
29. Jones JT, Akita RW, Sliwkowski MX. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett 1999; 447: 227-31.
30. Corfas G, Roy K, Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004; 7: 575-80.
31. Mosesson Y, Yarden Y. Oncogenic growth factor receptors: implications for signal transduction therapy. Semin Cancer Biol 2004; 14: 262-70.
32. Loeb JA. Neuregulin: an activity-dependent synaptic modulator at the neuromuscular junction. J Neurocytol 2003; 32: 649-64.
33. Wang JY, Miller SJ, Falls DL. The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain. J Biol Chem 2001; 276: 2841-51.
34. Falls DL. Neuregulins and the neuromuscular system: 10 years of answers and questions. J Neurocytol 2003; 32: 619-47.
35. Bacus SS, Zelnick CR, Plowman G, Yarden Y. Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior. Am J Clin Pathol 1994; 102(4 Suppl 1): S13-24.
36. Negro A, Brar BK, Lee KF. Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog Horm Res 2004; 59: 1-12.
37. Rimer M. Neuregulins: primary or secondary signals for the control of synapse-specific gene expression. J Neurocytol 2003; 32: 665-75.
38. Ma L, Huang YZ, Pitcher GM, et al. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J Neurosci 2003; 23: 3164-75.
39. Lai C. Peripheral glia: Schwann cells in motion. Curr Biol 2005; 15(9): R332-4.
40. Sandrock AW Jr, Dryer SE, Rosen KM, et al. Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in viro. Science 1997; 276: 599-603.
41. Wolpowitz D, Mason TB, Dietrich P, Mendelsohn M, Talmage DA, Role LW. Cysteine-rich domain isoforms of the neuregulin-1 gene we required for maintenance of peripheral synapses. Neuron 2000; 25: 79-91.
42. Huang YZ, Wang Q, Won S, Luo ZG, Xiong WC, Mei L. Compartmentalized NRG signaling and PDZ domain-containing proteins in synapse structure and function. Int J Dev Neurosci 2002; 20: 173-85.
43. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 1993; 72: 801-15.
44. Altiok N, Bessereau JL, Changeux JP. ErbB3 and ErbB2/neu mediate the effect of beregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate. EMBO J 1995; 14: 4258-66.
45. Won S, Si J, Colledge M, Ravichandran KS, Froehner SC, Mei L. Neuregulin-increased expression of acetylcholine receptor epsilon-subunit gene requires ErbB interaction with Shc. J Neurochem 1999; 73: 2358-68.
46. Li Q, Esper RM, Loeb JA. Synergistic effects of neuregulin and agrin on muscle acetylcholine receptor expression. Mol Cell Neurosci 2004; 26: 558-69.
47. Ozaki M, Sasner M, Yano R, Lu HS, Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997; 390: 691-4.
48. Subramony P, Dryer SE. Neuregulins stimulate the functional expression of Ca2+-activated K+ channels in developing chicken parasympathetic neurons. Proc Natl Acad Sci U S A 1997; 94(11): 5934-8.
49. Yang X, Kuo Y, Devay P, Yu C, Role L. A cysteine-rich isoform of neuregulin controls the level of expression of neuronal nicotinic receptor channels during synaptogenesis. Neuron 1998; 20: 255-70.
50. Rieff HI, Raetzman LT, Sapp DW, Yeh HH, Siegel RE, Corfas G. Neuregulin induces GABA(A) receptor subunit expression, and neurite outgrowth in cerebellar granule cells. J Neurosci 1999; 19: 10757-66.
51. Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25: 4974-84.
52. Escher P, Lacazette E, Courtet M, et al. Synapses form in skeletal muscles lacking neuregulin receptors. Science 2005; 308: 1920-3.
53. Sanes JR, Lichtman JW. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2001; 2: 791-805.
54. Hansen MR, Vijapurkar U, Koland JG, Green SH. Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins. Hear Res 2001; 161: 87-98.
55. Taveggia C, Zanazzi G, Petrylak A, et al. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 2005; 47: 681-94.
56. Roysommuti S, Carroll SL, Wyss JM. Neuregulin-1beta modulates in vivo entorhinal-hippocampal synaptic transmission, in adult rats. Neuroscience 2003; 121: 779-85.
57. Ozaki M, Itoh K, Miyakawa Y, Yishida H, Hashikawa, T. Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner. J Neuro-Chem 2004; 91: 176-88.
58. Kwon OB, Longart M, Vullhorst D, Hoffman DA, Buonanno A. Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci 2005; 25: 9378-83.
59. Weinstein EJ, Grimm S, Leder P. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Oncogene 1998; 17: 2107-13.
60. Weinstein EJ, Leder P. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Cancer Res 2000; 60: 3856-61.
61. Honma Y, Kiyosawa H, Mori T, et al. Eos: a novel member of the Ikaros gene family expressed predominantly in the developing nervous system. FEBS Lett 1999; 447: 76-80.
62. Perdonno J, Holmes M, Chong B, Crossley M. Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. J Biol Chem 2000; 275: 38347-54.
63. Perdomo J, Crossley M. The Ikaros family protein Eos associates with C-terminal-binding protein corepressors. Eur J Biochem 2002; 269: 5885-92.
64. Westman BJ, Perdomo J, Matthews JM, Crossley M, Mackay JP. Structural studies on a protein-binding zinc-finger domain of Eos reveal both similarities and differences to classical zinc fingers. Biochemistry 2004; 43: 13318-27.
65. Huang YZ, Won S, Ali DW, et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000; 26: 443-55.
66. Kennedy MB. Signal-processing machines at the postsynaptic density. Science 2000; 290: 750-4.
67. Scannevin RH, Huganir RL. Postsynaptic organization and regulation of excitatory synapses. Nat Rev Neurosci 2000; 1: 133-41.
68. Ansved T, Larsson L. Quantitative and qualitative morphological properties of the soleus motor nerve and the L5 ventral root in young and old rats. Relation to the number of soleus muscle fibers. J Neurol Sci 1990; 96: 269-82.
69. Verdu E, Ceballos D, Vilches JJ, Navarro X. Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst 2000; 5: 191-208.
70. Bao J, Lei D, Du Y, Ohlemiller KK, Beaudet AL, Role LW. Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging. J Neurosci 2005; 25: 3041-5.
71. Bertoni-Freddari C, Fattoretti P, Paoloni R, Caselli U, Galeazzi L, Meier-Ruge W. Synaptic structural dynamics and aging. Gerontology 1996; 42: 170-80.
72. Foster TC, Norris CM. Age-associated changes in Ca(2+)-dependent processes: relation to hippocampal synaptic plasticity, Hippocampus 1997; 7: 602-12.
73. Long JM, Mouton PR, Jucker M, Ingram DK. What counts in brain aging? Design-based stereological analysis of cell number. J Gerontol A Biol Sci Med Sci 1999; 54: B407-17.
74. Uylings HB, de Brabander JM. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn 2002; 49: 268-76.
75. Rosenzweig ES, Barnes CA. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 2003; 69: 143-79.
76. Hof PR, Morrison JH. The aging brain: morphomolecular senescence of cortical circuits. Trends Neurosci 2004; 27: 607-13.
77. Radley JJ, Morrison JH. Repeated stress and structural plasticity in the brain. Ageing Res Rev 2005; 4: 271-87.
78. Buonanno A, Fischbach GD. Neuregulin and ErbB receptor-signaling pathways in the nervous system. Curr Opin Neurobiol 2001; 11: 287-96.
79. Sapru MK. Neuregulin-1 regulates expression of the Ets-2 transcription factor. Life Sci 2001; 69: 2663-74.
80. Loeb JA, Hmatlcha A, Fischbach GD, Land SJ, Zakarian VL. Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotrophic factors. J Neurosci 2002; 22: 2206-14.
81. Law AJ, Shannon Weickert C, Hyde TM, Kleinman JF, Harrison PJ. Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 2004; 127: 125-36.
82. Li Q, Esper RM, Loeb JA. Synergistic effects of neuregulin and agrin on muscle acetylcholine receptor expression. Mol Cell Neurosci 2004; 26: 558-69.
83. Yang XL, Huang YZ, Xiong WC, Mei L. Neuregulin-induccd expression of the acetylcholine receptor requires endocytosis of ErbB receptors. Mol Cell Neurosci 2005; 28: 335-46.
84. Frenzel KE, Falls DL. Neuregulin-1 proteins in rat brain and transfected cells are localized to lipid rafts. J Neurochem 2001; 77: 1-12.
85. Eilam R, Pinkas-Kramarski R, Ratzkin BJ, Segal M, Yarden Y. Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proc Natl Acad Sci U S A 1998; 95: 1888-93.
86. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-92.
87. Corvin AP, Morris DW, McGhee K, et al. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004; 9: 208-13.
88. Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 2005; 147: 319-45.
89. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68.
90. Rimer M, Barrett DW, Maldonado MA, Vock VM, Gonzalez-Lima F. Neuregulin-1 immunoglobolin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition. Neuroreport 2005; 16: 271-5.
91. Thiselton DL, Webb BT, Neale BM, et al. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry 2004; 9: 777-83.
92. Duan J, Martinez M, Sanders AR, et al. Neuregulin 1 (NRG1) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychol Med 2005; 35: 1599-610.
93. Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci 2005; 25: 4974-84.
94. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA. Expression of neureguins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 1997; 17: 1642-59.
95. Huijbregts RP, Roth KA, Schmidt RE, Carroll SL. Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth factor beta3 in myelinating Schwann cells. J Neurosci 2003; 23: 7269-80.
96. Stonecypher MS, Byer SJ, Grizzle WE, Carroll SL. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene 2005; 24: 5589-605.
97. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004; 9: 299-307.
98. Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 2004; 63: 1155-62.
99. Small DH. Mechanisms of synaptic homeostasis in Alzheimer's disease. Curr Alzheimer Res 2004; 1: 27-32.
100. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004; 44: 181-93.
101. Ni CY, Murphy MP, Golde TE, Carpenter G. gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 2001; 294: 2179-81.
102. Lee HJ, Jung KM, Huang YZ, et al. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. J Biol Chem 2002; 277: 6318-23.